By Vivek Kumar M and Bharath Rajeswaran (Reuters) -Indian equity benchmarks posted a second straight weekly loss, weighed ...

Details of a preliminary accident report have been submitted to officials, according to the Times of India. It could be ...

Glenmark Pharmaceuticals Ltd.’s licensing pact with AbbVie Inc. for its blood cancer drug is boosting optimism over Indian ...

India’s five highest-priced stocks are trading at premiums compared to their industry peers or historical valuations, despite ...

The unlisted securities market, long viewed as a prized arena for early-stage value hunting, is now confronting a reality ...

The Sensex and the Nifty 50 declined by almost a per cent each on Friday, July 11. The Sensex closed 690 points, or 0.83 per ...

With the stock currently priced at Rs 2,377.40, Colgate Palmolive (India) experienced a notable decline today, influenced by ...

Insider and promoter selling reached $11 billion in just the past month, bringing the total to $30 billion in the first half ...

A temporary trading ban imposed by India’s securities regulator on Jane Street Group LLC is fueling concerns that volumes in ...

Indian equity benchmarks ended little changed on Monday as gains in consumer stocks, led by Godrej Consumer, helped offset ...

The B2B education platform views its listing on Indian bourses as a major step towards enhancing its global expansion.

Get a daily digest of key news moving Indian markets, including BSE options, real estate, and agrochemicals recovery.